International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Spiros Miyakis, Steven A. Krilis, Anǵela Tincani et al.|Journal of Thrombosis and Haemostasis|2006Cited by 7.1k
Endothelial cells as target for antiphospholipid antibodies. Human Polyclonal and Monoclonal Anti‐β<sub>2</sub>‐Glycoprotein I Antibodies React In Vitro with Endothelial Cells Through Adherent β<sub>2</sub>‐Glycoprotein I and Induce Endothelial ActivationNicoletta Del Papa, Pier Luigi Meroni, L Guidali et al.|Arthritis & Rheumatism|1997Cited by 290
Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndromeAngelo Valerio Marzano, Massimo Cugno, Daniele Fanoni et al.|Clinical & Experimental Immunology|2014Cited by 239
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6Yeny Martinez de la Torre, Alberto Mantovani, Chiara Buracchi et al.|Proceedings of the National Academy of Sciences|2007Cited by 178
European consensus statement on the terminology used in the management of lupus glomerulonephritisCaroline Gordon, G. R. V. Hughes, David Jayne et al.|Lupus|2009Cited by 150